The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Aneurysmal Subarachnoid Hemorrhage-Global Market Insights and Sales Trends 2024
Synopsis
The global Aneurysmal Subarachnoid Hemorrhage market size is expected to reach US$ 175.3 million by 2029, growing at a CAGR of 2.0% from 2023 to 2029. The market is mainly driven by the significant applications of Aneurysmal Subarachnoid Hemorrhage in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Aneurysmal Subarachnoid Hemorrhage market. Computed Tomography (CT) Scan, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Magnetic Resonance Imaging (MRI) segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Aneurysmal Subarachnoid Hemorrhage, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Aneurysmal Subarachnoid Hemorrhage market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Aneurysmal Subarachnoid Hemorrhage market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Aneurysmal Subarachnoid Hemorrhage sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Aneurysmal Subarachnoid Hemorrhage covered in this report include Edge Therapeutics, Actelion Pharmaceuticals, Arbor Pharmaceuticals, Mayfield Brain & Spine, Europa Group, GE, Philips, Siemens and Trivitron, etc.
The global Aneurysmal Subarachnoid Hemorrhage market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Edge Therapeutics
Actelion Pharmaceuticals
Arbor Pharmaceuticals
Mayfield Brain & Spine
Europa Group
GE
Philips
Siemens
Trivitron
Toshiba
Global Aneurysmal Subarachnoid Hemorrhage market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Aneurysmal Subarachnoid Hemorrhage market, Segment by Type:
Computed Tomography (CT) Scan
Magnetic Resonance Imaging (MRI)
Lumbar Puncture
Xanthochromia
Cerebral Angiography
Transcranial Doppler Ultrasound
Global Aneurysmal Subarachnoid Hemorrhage market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Aneurysmal Subarachnoid Hemorrhage companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Aneurysmal Subarachnoid Hemorrhage market size is expected to reach US$ 175.3 million by 2029, growing at a CAGR of 2.0% from 2023 to 2029. The market is mainly driven by the significant applications of Aneurysmal Subarachnoid Hemorrhage in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Aneurysmal Subarachnoid Hemorrhage market. Computed Tomography (CT) Scan, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Magnetic Resonance Imaging (MRI) segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Aneurysmal Subarachnoid Hemorrhage, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Aneurysmal Subarachnoid Hemorrhage market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Aneurysmal Subarachnoid Hemorrhage market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Aneurysmal Subarachnoid Hemorrhage sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Aneurysmal Subarachnoid Hemorrhage covered in this report include Edge Therapeutics, Actelion Pharmaceuticals, Arbor Pharmaceuticals, Mayfield Brain & Spine, Europa Group, GE, Philips, Siemens and Trivitron, etc.
The global Aneurysmal Subarachnoid Hemorrhage market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Edge Therapeutics
Actelion Pharmaceuticals
Arbor Pharmaceuticals
Mayfield Brain & Spine
Europa Group
GE
Philips
Siemens
Trivitron
Toshiba
Global Aneurysmal Subarachnoid Hemorrhage market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Aneurysmal Subarachnoid Hemorrhage market, Segment by Type:
Computed Tomography (CT) Scan
Magnetic Resonance Imaging (MRI)
Lumbar Puncture
Xanthochromia
Cerebral Angiography
Transcranial Doppler Ultrasound
Global Aneurysmal Subarachnoid Hemorrhage market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Aneurysmal Subarachnoid Hemorrhage companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Aneurysmal Subarachnoid Hemorrhage
1.1 Aneurysmal Subarachnoid Hemorrhage Market Overview
1.1.1 Aneurysmal Subarachnoid Hemorrhage Product Scope
1.1.2 Aneurysmal Subarachnoid Hemorrhage Market Status and Outlook
1.2 Global Aneurysmal Subarachnoid Hemorrhage Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Aneurysmal Subarachnoid Hemorrhage Market Size by Region (2018-2029)
1.4 Global Aneurysmal Subarachnoid Hemorrhage Historic Market Size by Region (2018-2023)
1.5 Global Aneurysmal Subarachnoid Hemorrhage Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Aneurysmal Subarachnoid Hemorrhage Market Size (2018-2029)
1.6.1 North America Aneurysmal Subarachnoid Hemorrhage Market Size (2018-2029)
1.6.2 Europe Aneurysmal Subarachnoid Hemorrhage Market Size (2018-2029)
1.6.3 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size (2018-2029)
1.6.4 Latin America Aneurysmal Subarachnoid Hemorrhage Market Size (2018-2029)
1.6.5 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size (2018-2029)
2 Aneurysmal Subarachnoid Hemorrhage Market by Type
2.1 Introduction
2.1.1 Computed Tomography (CT) Scan
2.1.2 Magnetic Resonance Imaging (MRI)
2.1.3 Lumbar Puncture
2.1.4 Xanthochromia
2.1.5 Cerebral Angiography
2.1.6 Transcranial Doppler Ultrasound
2.2 Global Aneurysmal Subarachnoid Hemorrhage Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Aneurysmal Subarachnoid Hemorrhage Historic Market Size by Type (2018-2023)
2.2.2 Global Aneurysmal Subarachnoid Hemorrhage Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Aneurysmal Subarachnoid Hemorrhage Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Aneurysmal Subarachnoid Hemorrhage Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Aneurysmal Subarachnoid Hemorrhage Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Revenue Breakdown by Type (2018-2029)
3 Aneurysmal Subarachnoid Hemorrhage Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Aneurysmal Subarachnoid Hemorrhage Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Aneurysmal Subarachnoid Hemorrhage Historic Market Size by Application (2018-2023)
3.2.2 Global Aneurysmal Subarachnoid Hemorrhage Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Aneurysmal Subarachnoid Hemorrhage Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Aneurysmal Subarachnoid Hemorrhage Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Aneurysmal Subarachnoid Hemorrhage Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Revenue Breakdown by Application (2018-2029)
4 Aneurysmal Subarachnoid Hemorrhage Competition Analysis by Players
4.1 Global Aneurysmal Subarachnoid Hemorrhage Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Aneurysmal Subarachnoid Hemorrhage as of 2022)
4.3 Date of Key Players Enter into Aneurysmal Subarachnoid Hemorrhage Market
4.4 Global Top Players Aneurysmal Subarachnoid Hemorrhage Headquarters and Area Served
4.5 Key Players Aneurysmal Subarachnoid Hemorrhage Product Solution and Service
4.6 Competitive Status
4.6.1 Aneurysmal Subarachnoid Hemorrhage Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Edge Therapeutics
5.1.1 Edge Therapeutics Profile
5.1.2 Edge Therapeutics Main Business
5.1.3 Edge Therapeutics Aneurysmal Subarachnoid Hemorrhage Products, Services and Solutions
5.1.4 Edge Therapeutics Aneurysmal Subarachnoid Hemorrhage Revenue (US$ Million) & (2018-2023)
5.1.5 Edge Therapeutics Recent Developments
5.2 Actelion Pharmaceuticals
5.2.1 Actelion Pharmaceuticals Profile
5.2.2 Actelion Pharmaceuticals Main Business
5.2.3 Actelion Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Products, Services and Solutions
5.2.4 Actelion Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Revenue (US$ Million) & (2018-2023)
5.2.5 Actelion Pharmaceuticals Recent Developments
5.3 Arbor Pharmaceuticals
5.3.1 Arbor Pharmaceuticals Profile
5.3.2 Arbor Pharmaceuticals Main Business
5.3.3 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Products, Services and Solutions
5.3.4 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Revenue (US$ Million) & (2018-2023)
5.3.5 Mayfield Brain & Spine Recent Developments
5.4 Mayfield Brain & Spine
5.4.1 Mayfield Brain & Spine Profile
5.4.2 Mayfield Brain & Spine Main Business
5.4.3 Mayfield Brain & Spine Aneurysmal Subarachnoid Hemorrhage Products, Services and Solutions
5.4.4 Mayfield Brain & Spine Aneurysmal Subarachnoid Hemorrhage Revenue (US$ Million) & (2018-2023)
5.4.5 Mayfield Brain & Spine Recent Developments
5.5 Europa Group
5.5.1 Europa Group Profile
5.5.2 Europa Group Main Business
5.5.3 Europa Group Aneurysmal Subarachnoid Hemorrhage Products, Services and Solutions
5.5.4 Europa Group Aneurysmal Subarachnoid Hemorrhage Revenue (US$ Million) & (2018-2023)
5.5.5 Europa Group Recent Developments
5.6 GE
5.6.1 GE Profile
5.6.2 GE Main Business
5.6.3 GE Aneurysmal Subarachnoid Hemorrhage Products, Services and Solutions
5.6.4 GE Aneurysmal Subarachnoid Hemorrhage Revenue (US$ Million) & (2018-2023)
5.6.5 GE Recent Developments
5.7 Philips
5.7.1 Philips Profile
5.7.2 Philips Main Business
5.7.3 Philips Aneurysmal Subarachnoid Hemorrhage Products, Services and Solutions
5.7.4 Philips Aneurysmal Subarachnoid Hemorrhage Revenue (US$ Million) & (2018-2023)
5.7.5 Philips Recent Developments
5.8 Siemens
5.8.1 Siemens Profile
5.8.2 Siemens Main Business
5.8.3 Siemens Aneurysmal Subarachnoid Hemorrhage Products, Services and Solutions
5.8.4 Siemens Aneurysmal Subarachnoid Hemorrhage Revenue (US$ Million) & (2018-2023)
5.8.5 Siemens Recent Developments
5.9 Trivitron
5.9.1 Trivitron Profile
5.9.2 Trivitron Main Business
5.9.3 Trivitron Aneurysmal Subarachnoid Hemorrhage Products, Services and Solutions
5.9.4 Trivitron Aneurysmal Subarachnoid Hemorrhage Revenue (US$ Million) & (2018-2023)
5.9.5 Trivitron Recent Developments
5.10 Toshiba
5.10.1 Toshiba Profile
5.10.2 Toshiba Main Business
5.10.3 Toshiba Aneurysmal Subarachnoid Hemorrhage Products, Services and Solutions
5.10.4 Toshiba Aneurysmal Subarachnoid Hemorrhage Revenue (US$ Million) & (2018-2023)
5.10.5 Toshiba Recent Developments
6 North America
6.1 North America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Aneurysmal Subarachnoid Hemorrhage Market Dynamics
11.1 Aneurysmal Subarachnoid Hemorrhage Industry Trends
11.2 Aneurysmal Subarachnoid Hemorrhage Market Drivers
11.3 Aneurysmal Subarachnoid Hemorrhage Market Challenges
11.4 Aneurysmal Subarachnoid Hemorrhage Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
